Taiji Group: Exclusive products in the future market is huge

Reasons for Stock selection: May 9, 2009, the Ministry of Health, in conjunction with the World Health Organization and other national Influenza A (H1N1) experience and relevant information, research and published the "Swine Flu diagnosis and Treatment Program (2009 Trial version of the first edition)", the proposed Chinese herbal medicine involved in the listed companies have Taiji group.　　This is the influenza A (H1N1), we are most optimistic about the Qi series, the production of Qi Qi drugs listed companies have Taiji group, the new drug industry. Selected gold Stocks: Taiji Group (600129). The Qi Qi oral liquid is the Taiji group exclusive product, by 100% Holding Taiji fuling pharmacy and 75% holding Sichuan Taiji Pharmaceutical production, is the national annual sales biggest, the annual sales highest brand, 2007 sales 200 million Yuan, 2008 sales 320 million yuan. There are three factors in 2009 that will promote the continued substantial growth of the patchouli healthy oral liquid. First, in 2008, the company's ex-factory price of patchouli positive oral liquid price increases 18%, from 2.8 yuan/box to 3.3 yuan/box, as the 2008 three quarter began to raise prices, the effect will be in 2009; The ex-factory price only 3.3 yuan, retail price of about 6 yuan, entered the list of basic drugs, from 2007 has begun to enter the community hospital and rural hospitals, and this piece of the market is very large; Finally, the health care programme for swine flu (the first edition of the 2009 Trial Edition), released by the ministry, mentions the Qi series, Another driver of the company's products. Sales in 2009 are expected to increase by more than 30%, sales revenue will exceed 400 million yuan.